XML 78 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Operating activities            
Net income (loss) $ 450 $ (9,700)        
Adjustments to reconcile net income (loss) to net cash used in operating activities:            
Amortization expense 10,295 3,688 $ 14,752      
Depreciation expense 198 184        
Stock-based compensation expense 4,951 4,263        
Non-cash lease expense 18 114        
Non-cash interest expense for amortization of debt discount and issuance costs 1,336          
Changes in operating assets and liabilities:            
Accounts receivable (12,474) (7,193)        
Inventory (6,714) (924)        
Prepaid expenses and other assets (2,990) 76        
Accounts payable (108) 1,583        
Accrued expenses (15,968) (8,263)        
Accrued rebates, returns and discounts 14,337 7,545        
Operating lease assets and liabilities   734        
Other long-term liabilities   (676)        
Net cash used in operating activities (6,669) (8,569)        
Investing activities            
Purchase of intangible asset (366,811)          
Purchases of property and equipment (836) (3,323)        
Net cash used in investing activities (367,647) (3,323)        
Financing activities            
Proceeds from issuances of common stock from employee stock purchase plans 357 444        
Proceeds from the exercise of stock options 4,454 213        
Payments made for employee restricted stock tax withholdings (1,358) (488)        
Proceeds from issuance of term note, net of issuance costs of $2,200 192,373          
Proceeds from convertible senior notes, net of issuance costs of $4,956 138,794          
Repayment of term loan (11,500)          
Net cash provided by financing activities 323,120 169        
Net decrease in cash, cash equivalents and restricted cash (51,196) (11,723)        
Cash, cash equivalents and restricted cash at beginning of period 170,019 146,633 146,633      
Cash, cash equivalents and restricted cash at end of period 118,823 134,910 170,019      
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:            
Cash and cash equivalents       $ 116,178 $ 170,019 $ 134,910
Restricted cash       2,645    
Total cash, cash equivalents and restricted cash 118,823 134,910 $ 146,633 $ 118,823 $ 170,019 $ 134,910
Supplemental disclosure of cash flow information            
Cash paid for interest 3,456 178        
Supplemental disclosure of non-cash activities            
Acquisition of property and equipment in accounts payable and accrued expenses 392 810        
Asset acquisition transaction costs in accounts payable and accrued expenses 1,415          
Accrued royalties discharged upon closing of asset acquisition 1,145          
Inventory used in the construction and installation of property and equipment 394 0        
Term notes issuance costs in accounts payable and accrued expenses 256          
Convertible senior notes issuance costs in accounts payable and accrued expenses $ 517          
Receivable from stock option exercises in other current assets   33        
Operating lease assets assumed   9,957        
Operating lease liabilities assumed   $ 10,691